Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.53 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | GGT1 | P19440 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.51 |
| ▸ | RXRB | P28702 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29374906 | 1.00 | KDM4E (0.53) | KDM4EHSD17B10ALDH1A1HPGDESR1 | |
| SCHEMBL9588403 | 0.89 | HTT (0.62) | KDM4EHSD17B10ALDH1A1HPGDESR1 | |
| SCHEMBL5784212 | 0.86 | ELANE (0.52) | ALDH1A1RXRARXRBRXRGKCNK3 | |
| SCHEMBL240363 | 0.85 | FABP4 (0.49) | KDM4EHSD17B10ALDH1A1HPGDESR1 | |
| SCHEMBL4247156 | 0.85 | KDM4E (0.50) | KDM4EHSD17B10ALDH1A1HPGDESR1 | |
| SCHEMBL20516075 | 0.85 | KDM4E (0.55) | KDM4EHSD17B10ALDH1A1HPGDESR1 | |
| SCHEMBL6957926 | 0.84 | KCNK3 (0.50) | ALDH1A1RXRARXRBRXRGKCNK3 | |
| SCHEMBL16093747 | 0.83 | RXRA (0.44) | KDM4EHSD17B10ALDH1A1HPGDESR1 | |
| SCHEMBL1970631 | 0.83 | ALB (0.52) | KDM4EHSD17B10ALDH1A1HPGDESR1 | |
| SCHEMBL10937430 | 0.83 | ELANE (0.57) | ALDH1A1MAPTRXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118619869-B | Halogen-containing lithium ion eutectic crystal and preparation method and application thereof | 佛山大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118619869-A | Halogen-containing lithium ion eutectic crystal and preparation method and application thereof | 佛山大学 | 2024-09-10 | — | — | CN | claimed |
| US-20240027903-A1 | Resist Material And Patterning Process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-25 | — | — | US | claimed |
| EP-4288412-A1 | MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME | Rappta Therapeutics Oy (FI) | 2023-12-13 | — | — | EP | claimed |
| CN-116120271-A | Genipin derivative and preparation method and application thereof | 广东工业大学 | 2023-05-16 | — | — | CN | claimed |
| EP-4065577-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Bayer Aktiengesellschaft (DE) | 2022-10-05 | — | — | EP | claimed |
| WO-2022167866-A1 | MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME | RAPPTA THERAPEUTICS OY (FI) | 2022-08-11 | — | — | WO | claimed |
| WO-2021105091-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-06-03 | — | — | WO | claimed |
| CN-107406469-B | For extracting C from aqueous streams1To C4Quaternary arylcarboxylate salt compositions of carboxylic acids | 伊士曼化工公司 | 2021-04-30 | — | — | CN | claimed |
| EP-3390414-B1 | QUATERNARY ARYLCARBOXYLATE COMPOSITIONS FOR EXTRACTING C1 TO C4 CARBOXYLIC ACIDS FROM AQUEOUS STREAMS | EASTMAN CHEM CO (US) | 2020-05-27 | — | — | EP | claimed |
| EP-3390414-A1 | QUATERNARY ARYLCARBOXYLATE COMPOSITIONS FOR EXTRACTING C1 TO C4 CARBOXYLIC ACIDS FROM AQUEOUS STREAMS | Eastman Chemical Company (US) | 2018-10-24 | — | — | EP | claimed |
| US-20180198069-A1 | P-Doping Cross-Linking Of Organic Hole Transporters | SIEMENS AKTIENGESELLSCHAFT (DE) | 2018-07-12 | — | — | US | claimed |
| EP-3057151-B1 | BISMUTH AND TIN COMPLEXES AS P DOTANDS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | SIEMENS AG (DE) | 2018-01-31 | — | — | EP | claimed |
| WO-2017105476-A1 | QUATERNARY ARYLCARBOXYLATE COMPOSITIONS FOR EXTRACTING C1 TO C4 CARBOXYLIC ACIDS FROM AQUEOUS STREAMS | EASTMAN CHEMICAL COMPANY (US) | 2017-06-22 | — | — | WO | claimed |
| US-20170098787-A1 | MAIN GROUP METAL COMPLEXES AS P-DOPANTS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | SIEMENS AKTIENGESELLSCHAFT (DE) | 2017-04-06 | — | — | US | claimed |
| US-9611209-B1 | Quaternary arylcarboxylate compositions for extracting C1 to C4 carboxylic acids from aqueous streams | EASTMAN CHEMICAL COMPANY (US) | 2017-04-04 | — | — | US | claimed |
| EP-3057151-A1 | PRINCIPAL GROUP METAL COMPLEXES AS P DOTANDS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | Siemens Aktiengesellschaft (DE) | 2016-08-17 | — | — | EP | claimed |
| EP-2379558-B1 | NOVEL HETEROCYCLIC COMPOUNDS FOR USE AS METAP-2 INHIBITORS | MERCK PATENT GMBH (DE) | 2016-03-23 | — | — | EP | claimed |
| WO-2010129848-A2 | 2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDINE-4-CARBOXAMIDES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-11-11 | — | — | WO | claimed |
| US-5219477-A | Containing organometallic salts and inorganic metal borates; fromo reactinmetal hydroxide with phenols or aromatic carboxylic acid | THE DOW CHEMICAL COMPANY (US) | 1993-06-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170098787-A1 | MAIN GROUP METAL COMPLEXES AS P-DOPANTS FOR ORGANIC ELECTRONIC MATRIX MATERIALS | SCO2, SOD3, NCOA3 | KDM4E 1107/4885HSD17B10 2065/4885ALDH1A1 1949/4885 |
| US-20240027903-A1 | Resist Material And Patterning Process | LBR, HNRNPU, EWSR1 | KDM4E 778/4885HSD17B10 3657/4885ALDH1A1 4741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.